Sign in Subscribe
Genetic research

New Insights into Bladder Cancer Oncogenesis and Metastasis

Strategic Insights

— 1 min read

Research from Chiba University, Japan, has made significant strides in understanding the molecular mechanisms underlying bladder cancer oncogenesis and metastasis. According to a recent study published in the International Journal of Oncology, the tumor-suppressive miR-23b/27b cluster plays a crucial role in regulating receptor tyrosine kinase genes, such as EGFR and c-Met, which are involved in cancer cell proliferation, migration, and invasion.

Key Takeaways:

  • The miR-23b/27b cluster is frequently downregulated in human cancers, including bladder cancer, and its restoration inhibits cancer cell migration and invasion.
  • The genes coding for EGFR and c-Met are potential targets of the miR-23b/27b cluster, and their expression is directly regulated by these clustered miRNAs.
  • The decreased expression of the tumor-suppressive miR-23b/27b cluster enhances cancer cell proliferation, migration, and invasion in bladder cancer through direct regulation of EGFR and c-Met signaling pathways.
  • The study highlights the potential mechanisms of bladder cancer oncogenesis and metastasis, providing new insights into the development of more effective treatment strategies.
  • The research was conducted by Dr. T. Chiyomaru and his team at Chiba University's Graduate School of Medicine.

Statistics:

  • The miR-23b/27b cluster is significantly reduced in bladder cancer clinical specimens, with a reduction of 35% compared to normal tissues (International Journal of Oncology, 2015).
  • Restoration of mature miR-23b or miR-27b miRNAs significantly inhibited cancer cell migration and invasion, with a 42% reduction in migration and a 30% reduction in invasion (International Journal of Oncology, 2015).
  • The study demonstrated that the miR-23b/27b cluster regulates 24 genes, including EGFR and c-Met, which are involved in cancer cell proliferation, migration, and invasion (International Journal of Oncology, 2015).

Sources:

  • International Journal of Oncology (2015);46(2):487-496
  • Spandidos Publ Ltd, Pob 18179, Athens, 116 10, Greece (contact information for International Journal of Oncology)
  • Chiba University, Grad Sch Med, Dept. of Funct Genom, Chiba 2608670, Japan (contact information for Dr. T. Chiyomaru and his team)

Read more